Northwestern Mutual Investment Management Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,037
Closed -$1.84M 914
2021
Q2
$1.84M Buy
10,037
+71
+0.7% +$13K 0.03% 225
2021
Q1
$1.52M Sell
9,966
-2,043
-17% -$312K 0.03% 278
2020
Q4
$1.88M Sell
12,009
-122
-1% -$19.1K 0.02% 344
2020
Q3
$1.36M Hold
12,131
0.02% 399
2020
Q2
$1.36M Buy
12,131
+609
+5% +$68.4K 0.02% 400
2020
Q1
$1.04M Buy
11,522
+2,926
+34% +$263K 0.02% 421
2019
Q4
$930K Buy
8,596
+57
+0.7% +$6.17K 0.02% 536
2019
Q3
$836K Buy
8,539
+33
+0.4% +$3.23K 0.02% 556
2019
Q2
$1.11M Sell
8,506
-25,450
-75% -$3.33M 0.03% 424
2019
Q1
$4.59M Buy
33,956
+344
+1% +$46.5K 0.08% 204
2018
Q4
$3.27M Sell
33,612
-5,387
-14% -$524K 0.05% 241
2018
Q3
$5.42M Sell
38,999
-3,609
-8% -$502K 0.08% 207
2018
Q2
$5.29M Buy
42,608
+2,258
+6% +$280K 0.08% 219
2018
Q1
$4.5M Sell
40,350
-10,113
-20% -$1.13M 0.07% 236
2017
Q4
$6.04M Buy
50,463
+425
+0.8% +$50.8K 0.1% 200
2017
Q3
$7.02M Sell
50,038
-1,491
-3% -$209K 0.12% 172
2017
Q2
$6.27M Buy
51,529
+6,124
+13% +$745K 0.11% 187
2017
Q1
$5.51M Buy
45,405
+19,655
+76% +$2.38M 0.1% 183
2016
Q4
$3.15M Buy
25,750
+3,564
+16% +$436K 0.06% 189
2016
Q3
$2.72M Buy
22,186
+13,638
+160% +$1.67M 0.06% 184
2016
Q2
$998K Sell
8,548
-53
-0.6% -$6.19K 0.02% 284
2016
Q1
$1.2M Buy
8,601
+41
+0.5% +$5.71K 0.03% 250
2015
Q4
$1.63M Buy
8,560
+274
+3% +$52.3K 0.03% 257
2015
Q3
$1.3M Buy
8,286
+814
+11% +$127K 0.03% 308
2015
Q2
$1.35M Buy
7,472
+142
+2% +$25.7K 0.03% 337
2015
Q1
$1.27M Buy
+7,330
New +$1.27M 0.03% 359